IAM
ATRS

Iridian Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Iridian Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-73,670
Closed -$197K – 117
2014
Q2 		$197K Sell
73,670
-22,600
-23% -$68K ﹤0.01% 96
2014
Q1 		$337K Sell
96,270
-31,740
-25% -$141K ﹤0.01% 77
2013
Q4 		$572K Buy
128,010
+50,070
+64% +$204K 0.01% 55
2013
Q3 		$316K Buy
77,940
+32,780
+73% +$143K ﹤0.01% 119
2013
Q2 		$188K Buy
+45,160
New +$174K ﹤0.01% 130

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Iridian Asset Management's ATRS Position: Q3 2014 in Review

Iridian Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2014, closing a stake of 73,670 shares — an estimated $197K sold.

Iridian Asset Management first reported a position in ATRS in Q2 2013 and held it in 5 quarters. The position peaked at $572K in Q4 2013. 82 funds tracked by Wall St. Rank hold ATRS as of Q3 2014.

  • Iridian Asset Management reported no remaining Antares Pharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Iridian Asset Management sold 73,670 Antares Pharma, Inc. shares in Q3 2014, an estimated $197K.
  • Iridian Asset Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 5 quarters.
  • Iridian Asset Management's Antares Pharma, Inc. position peaked at $572K in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2014.

Based on Iridian Asset Management's 13F filing for Q3 2014, filed 7 Nov 2014.